BANL vs BRN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and no available Altman Z-Score, limiting bankruptcy risk assessment. Profitability metrics are deeply negative, with ROE at -14.24% and operating margin at -0.27%, while revenue has declined 4.4% year-over-year. Valuation ratios like Price/Sales of 0.02 and Price/Book of 0.42 suggest apparent cheapness, but these are offset by deteriorating fundamentals, lack of analyst coverage, and a technical trend scoring 0/100. The stock has lost over 90% of its value in the past five years, reflecting persistent operational and market challenges.
Barnwell Industries exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across nearly all health metrics. The company is suffering from a significant revenue contraction of 30.20% YoY and deep negative profitability, with an ROE of -71.16%. While the balance sheet is remarkably clean with a Debt/Equity ratio of 0.01, this lack of leverage cannot offset the operational collapse and consistent long-term price erosion. The combination of negative margins and bearish insider activity suggests a high-risk profile with no immediate catalyst for recovery.
Compare Another Pair
Related Comparisons
BANL vs BRN: Head-to-Head Comparison
This page compares CBL International Limited (BANL) and Barnwell Industries, Inc. (BRN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.